These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38702016)
1. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration. Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016 [TBL] [Abstract][Full Text] [Related]
2. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells. Lu Y Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells. Kang H; Ma D; Zhang J; Zhao J; Yang M BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085 [TBL] [Abstract][Full Text] [Related]
4. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability. Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860 [TBL] [Abstract][Full Text] [Related]
5. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR. Xie A; Xu X; Kuang P; Zhang L; Yu F Cell Death Dis; 2021 Aug; 12(9):804. PubMed ID: 34429402 [TBL] [Abstract][Full Text] [Related]
6. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
7. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma. Zhao X; Zhang W; Ji W Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349 [TBL] [Abstract][Full Text] [Related]
8. PLAU promotes cell proliferation and migration of head and neck cancer via STAT3 signaling pathway. Cui X; Sun H; Liu X; Bai Y; Bai Y; Cui Y; Wang B; Zhang S; Li X Exp Cell Res; 2024 May; 438(2):114056. PubMed ID: 38663475 [TBL] [Abstract][Full Text] [Related]
9. GATA-6 transcriptionally inhibits Shh to repress cell proliferation and migration in lung squamous cell carcinoma. Xu L; Deng S; Xiong H; Shi W; Luo S; Chen L Int J Biochem Cell Biol; 2019 Oct; 115():105591. PubMed ID: 31442607 [TBL] [Abstract][Full Text] [Related]
10. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells. Zhai J; Luo G Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888 [TBL] [Abstract][Full Text] [Related]
11. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis. Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697 [TBL] [Abstract][Full Text] [Related]
12. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA. Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C Life Sci; 2023 May; 321():121578. PubMed ID: 36958438 [TBL] [Abstract][Full Text] [Related]
13. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation. Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821 [TBL] [Abstract][Full Text] [Related]
14. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA. Ren P; Xing L; Hong X; Chang L; Zhang H Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048 [TBL] [Abstract][Full Text] [Related]
15. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma. Dong C; Zhao Y; Yang S; Jiao X J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154 [TBL] [Abstract][Full Text] [Related]
16. Silencing of long non-coding RNA SOX21-AS1 inhibits lung adenocarcinoma invasion and migration by impairing TSPAN8 via transcription factor GATA6. Xu Y; Wu H; Wu L; Xu L; Li J; Wang Q; Pu X Int J Biol Macromol; 2020 Dec; 164():1294-1303. PubMed ID: 32698071 [TBL] [Abstract][Full Text] [Related]
17. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression. Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070 [TBL] [Abstract][Full Text] [Related]
18. Role of downregulated ADARB1 in lung squamous cell carcinoma. Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472 [TBL] [Abstract][Full Text] [Related]
19. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior of Lung Squamous Cell Carcinoma H520 Cells]. Gou L; He Y; Qiu P; Huang B Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337 [TBL] [Abstract][Full Text] [Related]
20. HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma. Li Y; Wang Y; Wu R; Li P; Cheng Z Sci Rep; 2024 Jun; 14(1):13206. PubMed ID: 38851806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]